Canine Cirrhosis and Its Similarities to Human Liver Disease
Author Information
Author(s): Bart Spee, Brigitte Arends, Ted van den Ingh, Tania Roskams, Jan Rothuizen, Louis C. Penning
Primary Institution: Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, The Netherlands
Hypothesis
Are privately-owned dogs potential model animals for liver disease focusing on regenerative pathways?
Conclusion
Canine hepatitis and cirrhosis could be an important clinical model to evaluate novel interventions prior to human clinical trials.
Supporting Evidence
- Canine liver diseases are clinically comparable to human liver diseases.
- HGF-mediated regeneration pathways are similarly activated in both species.
- Canine models can bridge the gap between rodent models and human clinical situations.
Takeaway
This study shows that dogs with liver disease have similar healing processes to humans, which means they can help us test new treatments before using them on people.
Methodology
The study analyzed liver samples from dogs with various forms of hepatitis and cirrhosis, comparing them to human liver samples using PCR and Western blot techniques.
Potential Biases
Potential bias due to the small sample size and the specific breeds of dogs used.
Limitations
The etiology of canine hepatitis is largely unknown, which may affect the applicability of the findings.
Participant Demographics
Samples were obtained from privately owned dogs of different breeds and human patients predominantly male with cirrhosis.
Statistical Information
P-Value
p < 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website